Vestal Point Capital »

Surrozen shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Surrozen (SRZN) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Surrozen

Tip: Access up to 7 years of quarterly data

All positions including Surrozen held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Surrozen by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $9.9M 339k 29.13

More positions owned by Vestal Point Capital

Revolution Medicines (RVMD)
BioMarin Pharmaceutical (BMRN)
Abivax SA Sponsored Ads (ABVX)
Neurocrine Biosciences (NBIX)
Arrowhead Pharmaceuticals (ARWR)
Enliven Therapeutics (ELVN)
Repligen Corporation (RGEN)
Bicara Therapeutics (BCAX)
Nurix Therapeutics (NRIX)
Apogee Therapeutics (APGE)
Ascendis Pharma A/S Sponsored Adr (ASND)
Immunocore Holdings Ads (IMCR)
Taysha Gene Therapies Com Shs (TSHA)
Dyne Therapeutics (DYN)
Sanofi SA Sponsored Adr (SNY)

View all positions for Vestal Point Capital

Top funds holding Surrozen

TCG Crossover Management
Millennium Management
VR Adviser
Stempoint Capital
Boxer Capital Management
Braidwell
5AM Venture Management
Kalehua Capital Management
Vestal Point Capital
Vanguard Group
Vivo Capital
Perceptive Advisors
Woodline Partners
Balyasny Asset Management
Ikarian Capital

View all funds holding Surrozen